Race Oncology Limited logo

Race Oncology Limited

ASX:RAC.AX

Overview | Financials
Company Name Race Oncology Limited
Symbol RAC.AX
Currency AUD
Price 1.575
Market Cap 268,494,975
Dividend Yield 0%
52-week-range 0.64 - 2.09
Industry Biotechnology
Sector Healthcare
CEO Dr. Peter M. Smith Ph.D.
Website https://www.raceoncology.com

An error occurred while fetching data.

About Race Oncology Limited

Race Oncology Limited operates as a precision oncology company in Australia. The company is developing Zantrene, a potent small molecule inhibitor of the fatso/fat mass and obesity associated protein to treat for melanoma and clear cell renal cell carcinoma, as well as acute myeloid leukaemia, breast, and ovarian cancers, which

Related Stocks

Aroa Biosurgery Limited logo

Aroa Biosurgery Limited

ARX.AX

0.61 AUD

Paradigm Biopharmaceuticals Limited logo

Paradigm Biopharmaceuticals Limited

PAR.AX

0.225 AUD

Pacific Smiles Group Limited logo

Pacific Smiles Group Limited

PSQ.AX

1.89 AUD

Rhythm Biosciences Limited logo

Rhythm Biosciences Limited

RHY.AX

0.11 AUD

Cogstate Limited logo

Cogstate Limited

CGS.AX

0.965 AUD

Starpharma Holdings Limited logo

Starpharma Holdings Limited

SPL.AX

0.099 AUD

Anteris Technologies Ltd logo

Anteris Technologies Ltd

AVR.AX

10 AUD

PYC Therapeutics Limited logo

PYC Therapeutics Limited

PYC.AX

0.2 AUD

Immutep Limited logo

Immutep Limited

IMM.AX

0.29 AUD

AnteoTech Limited logo

AnteoTech Limited

ADO.AX

0.027 AUD

Financials

Numbers are in millions USD

Numbers are in millions USD